Study to Evaluate Orelabrutinib Tablets in Subjects With Hepatic Impairment and Healthy Subject
Clinical trial NCT05684653 · UNKNOWN
Trial details
- NCT number
- NCT05684653
- Sponsor
- Beijing InnoCare Pharma Tech Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-17
- Primary completion
- 2023-12-30
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.